Jamjoom Pharmaceuticals Factory (4015)
Tadawul
Closed
Aug 27, 2026
Day's Range
138.9052 wk Range
125.00Overview - 4015 - Jamjoom Pharmaceuticals Factory
Key Statistics
Valuation
Enterprise Value
9.62B
P/E (Trailing)
‪20.52‬
P/E (Forward)
‪17.94‬
PEG Ratio
‪-1.70‬
Price / Sales (TTM)
‪6.27‬
Price / Book
‪5.25‬
EV / EBITDA
‪17.67‬
Profitability
Gross Margin
‪65.94%‬
Profit Margin
‪30.54%‬
Operating Margin
‪32.78%‬
Return on Assets
‪14.13%‬
Return on Equity
‪26.99%‬
Ownership
Shares Outstanding
70.00M
Float
24.01M
Held by Insiders
‪61.38%‬
Held by Institutions
‪3.30%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪146.87‬
200-Day Avg
‪145.97‬
Dividends
Payout Ratio
‪58.22%‬
Frequency
Semi-Annual
Analyst Consensus
4 analysts
Market Cap - 4015 - Jamjoom Pharmaceuticals Factory
Peers - 4015 - Jamjoom Pharmaceuticals Factory
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Tadawul.
Profile Summary - 4015 - Jamjoom Pharmaceuticals Factory
About
Jamjoom Pharmaceuticals Factory is a prominent player in the pharmaceutical industry based in Saudi Arabia. As a manufacturer, the company's primary function is to develop, produce, and distribute a broad range of pharmaceutical products. Jamjoom Pharmaceuticals serves multiple sectors, including healthcare,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
